![Keeren Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Keeren Shah
Directeur Financier/CFO chez
ACTAVIA LIFE SCIENCES, INC.
Fortune : 28 201 $ au 30/06/2026
Profil
Keeren Shah is currently a Member at The Chartered Institute of Management Accountants.
Since 2020, serves as Chief Financial Officer at Actavia Life Sciences, Inc. Also since 2020, holds the position of Chief Financial Officer at OKYO Pharma Ltd. Since 2021, holds the role of Chief Financial Officer at AccuStem Sciences, Inc. Holds the positions of Chief Operating & Financial Officer and Chief Financial Officer at Tiziana Life Sciences Ltd. and Tiziana Life Sciences Ltd. (United Kingdom), respectively.
Formerly served as Finance Director at Rasna Therapeutics, Inc.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
OKYO PHARMA LIMITED 0,03 % | 08/06/2026 | 16 667 ( 0,03 % ) | 25 001 $ | 30/06/2026 |
| 31/03/2026 | 2 500 ( 0 % ) | 3 200 $ | 30/06/2026 | |
| 31/12/2024 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Keeren Shah
| Sociétés | Poste | Début |
|---|---|---|
| ACTAVIA LIFE SCIENCES, INC. | Directeur Financier/CFO | 31/07/2020 |
| WEST AFRICAN MINERALS CORP | Directeur Financier/CFO | 01/08/2020 |
| ACCM SCIE | Directeur Financier/CFO | 01/08/2021 |
| TIZIANA LIFE SCIENCES LTD | Directeur Financier/CFO | 01/03/2021 |
The Chartered Institute of Management Accountants
 The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Corporate Officer/Principal | - |
Tiziana Life Sciences Ltd. (United Kingdom)
 Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Directeur Financier/CFO | - |
Anciens postes connus de Keeren Shah
| Sociétés | Poste | Fin |
|---|---|---|
Rasna Therapeutics, Inc. /Old/
 Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University | Consumer Services |
OKYO Pharma Ltd.
 OKYO Pharma Ltd. BiotechnologyHealth Technology Develops next-generation therapeutics to improve the lives of patients suffering from inflammatory eye diseases | Health Technology |
Tiziana Life Sciences Ltd. (United Kingdom)
Tiziana Life Sciences Ltd. (United Kingdom) BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops transformative therapies for neurodegenerative and neuroinflammatory | Health Technology |
Rasna Therapeutics, Inc. /Old/
Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Develops cancer drugs | Distribution Services |
Actavia Life Sciences, Inc.
 Actavia Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
AccuStem Sciences, Inc.
 AccuStem Sciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures genomics-based personalized medicines for breast cancer patients | Health Technology |
Tiziana Life Sciences Ltd.
 Tiziana Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
